Related Experiment Video
Updated: May 16, 2026

Isolation of Culturable Yeasts and Molds from Soils to Investigate Fungal Population Structure
Published on: May 27, 2022
Azole resistance in Aspergillus: an emerging problem?
E Vermeulen1, S Cooreman, J Maertens
1Medical Diagnostic Sciences, UZ Leuven, Leuven, Belgium. edith.vermeulen@uzleuven.be
Abstract:
Reports of Aspergillus' azole resistance are emerging, and resistance is now recognised as a cause of treatment failure. The scope of this article is to describe the problem of resistance in Aspergillus: the epidemiology, clinical impact and the underlying molecular mechanisms. In patients with acute invasive aspergillosis, the probability that the patient harbours a resistant strain depends on the emergence of resistant strains in the environment (acquired resistance due to CYP51A mutations and/or natural resistant Aspergillus species). As environmental pan-azole resistance of Aspergillus fumigatus is reported in increasing numbers in the Netherlands, surveillance is warranted. Voriconazole currently remains the first line therapeutic agent for invasive aspergillosis in Belgium. In chronic (and chronically treated) Aspergillus infections,"in-patient" resistance development is possible, especially in the setting of aspergilloma. Culturing an isolate during therapy should therefore be a trigger to test susceptibility.
Insights
Emerging azole resistance in Aspergillus is a growing concern, causing treatment failures in invasive aspergillosis. Surveillance for resistant Aspergillus fumigatus strains is crucial, especially in environmental settings.
Area of Science:
- Mycology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Azole antifungal resistance in Aspergillus species is an increasing global health threat.
- This resistance is a significant cause of treatment failure in patients with invasive aspergillosis.
- Understanding the epidemiology, clinical impact, and molecular mechanisms of Aspergillus azole resistance is critical.
Purpose of the Study:
- To describe the multifaceted problem of azole resistance in Aspergillus.
- To elucidate the epidemiological trends and clinical consequences of resistant Aspergillus infections.
- To detail the molecular mechanisms underlying acquired and intrinsic azole resistance in Aspergillus species.
Main Methods:
- Review of current literature on Aspergillus azole resistance.
- Analysis of epidemiological data regarding resistant Aspergillus strains.
- Examination of molecular mechanisms, including CYP51A mutations and naturally resistant species.
Main Results:
- Resistance in Aspergillus can be acquired (e.g., CYP51A mutations) or intrinsic to certain species.
- Environmental emergence of resistant Aspergillus fumigatus, particularly pan-azole resistance, is increasing in regions like the Netherlands.
- Invasive aspergillosis treatment failure is linked to the presence of azole-resistant Aspergillus strains.
- In-patient resistance development can occur in chronic Aspergillus infections, such as aspergilloma.
Conclusions:
- Environmental surveillance for azole-resistant Aspergillus fumigatus is essential.
- Clinical isolates from patients undergoing antifungal therapy should be tested for susceptibility.
- Voriconazole remains a primary treatment for invasive aspergillosis, but resistance necessitates ongoing monitoring and susceptibility testing.
Related Concept Videos
Fungal Phylum Ascomycota
Fungal Group Zygomycota
Fungal Phylum Microsporidia
Antifungal Agents

